A gentler chemo schedule may match standard care in advanced pancreatic cancer
A systematic review of five real-world studies finds that a biweekly gemcitabine and nab-paclitaxel schedule matches standard survival outcomes in ...
A systematic review of five real-world studies finds that a biweekly gemcitabine and nab-paclitaxel schedule matches standard survival outcomes in ...
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most formidable challenges in oncology, persistently defying decades of therapeutic innovation and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine